This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Plan MTTP IHC in small-intestinal glandular cells and hepatocytes, where HPA reports cytoplasmic staining (HPA tissue IHC). Use the catalog antibody’s paraffin-section protocol and interpret staining with HPA’s uncertain reliability in mind (datasheet A01715-1; HPA tissue IHC).
Expected localisation, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected localisation | Cytoplasmic tissue staining (HPA tissue IHC) | |
| Staining pattern | Cytoplasmic in intestinal glandular cells and hepatocytes (HPA tissue IHC) | |
| Antigen retrieval | EDTA pH 8.0 HIER, heat-mediated (datasheet A01715-1) | |
| Positive control | Duodenum+2 more · see all | |
| Negative control | Adipose tissue+4 more · see all |
| Fixation | Keep paraffin-section fixation consistent. (standard IHC practice; not target-specific) | |
| Caveat | Presumed off-target staining; reliability uncertain (HPA tissue IHC) | |
| Regulation | Expression regulation unreported (UniProt) | |
| Isoform / epitope | 2 isoforms; epitope differences unreported (UniProt) |
The catalog antibody’s IHC-P protocol is accompanied by three published MTTP IHC protocols for chicken ovarian tissue, paired tumor samples, and additional MTTP-stained samples (PMC11951013; PMC9534973; PMC11055869).
| Sample | Paraffin-embedded human liver cancer tissue; fixative not specified (datasheet A01715-1) |
| Fixation | Image fixative and duration unreported (datasheet A01715-1); verify before use. |
| Sectioning | 4–5 µm sections on charged slides (standard) |
| Deparaffinisation | Xylene, graded ethanol series to water (standard) |
| Antigen retrieval | Heat retrieval: EDTA pH 8.0 (datasheet A01715-1); 20 min, 95–100 °C (standard) |
| Peroxidase block | 3% H2O2, 10 min, room temperature (standard) |
| Blocking | 10% goat serum (datasheet A01715-1) |
| Primary antibody | Rabbit anti-MTTP, 2-5μg/ml (datasheet A01715-1) |
| Primary incubation | Overnight at 4 °C (datasheet A01715-1) |
| Detection | Streptavidin-biotin complex (SABC), DAB chromogen (datasheet A01715-1) |
| Counterstain | Hematoxylin, blue, dehydrate and mount (standard) |
| Expected result | MTTP-positive staining in glandular cells of duodenum (HPA tissue IHC: High). HPA tissue profile: Cytoplasmic expression in liver and small intestine. No signal in the no-primary control. |
MTTP staining should appear mainly in the cytoplasm of duodenal and small-intestinal glandular cells, with a weaker signal in hepatocytes (HPA tissue IHC: high in intestinal glandular cells; medium in hepatocytes). Its supported endoplasmic-reticulum location gives a more specific localisation expectation than cytoplasm alone (HPA ICC-IF: ER supported; UniProt P55157: ER and Golgi). Interpret chromogenic IHC cautiously: HPA rates the tissue pattern uncertain and reports presumed off-target staining (HPA tissue IHC: uncertain).
| Cytoplasmic staining in intestinal glandular cells and hepatocytes, stronger in the intestine. | This fits the observed tissue pattern (HPA tissue IHC: high in duodenum and small intestine; medium in liver). Score the relevant cells and their cytoplasmic signal; HPA's uncertain reliability means the pattern alone does not prove specificity (HPA tissue IHC: uncertain). |
| Predominantly nuclear or sharply plasma-membrane staining in otherwise positive cells. | This conflicts with MTTP's reported intracellular locations and lack of a transmembrane segment (UniProt P55157: ER, Golgi, no transmembrane segment). Consider artefact or nonspecific staining; a cytoplasmic signal in the same section does not validate the discordant compartment. |
| Strong staining in adipocytes, marrow cells, or other cells reported as undetected. | These are discrepancies with the sampled HPA tissue observations (HPA tissue IHC: adipocytes and marrow hematopoietic cells not detected). Assess cross-reactivity or endogenous chromogen-generating activity before calling them MTTP-positive; an HPA 'not detected' result is not a universal absence claim. |
| Diffuse chromogen across tissue and empty areas, obscuring cell boundaries. | Treat this as background until the assay controls identify its source (general IHC practice). Distribution that does not track the expected glandular cells or hepatocytes is weak evidence for MTTP (HPA tissue IHC: cytoplasmic expression in liver and small intestine). |
| No detectable stain in duodenal or small-intestinal glandular cells. | A negative result in a reported high-staining tissue warrants a run-level check (HPA tissue IHC: high in duodenum and small intestine). Examine tissue preservation, retrieval, antibody dilution, detection, and controls using general IHC practice before interpreting the sample as biologically negative. |
| Tissue and cell selection | Duodenum or small intestine provides an observed high-staining reference; liver offers a medium-staining comparison (HPA tissue IHC). Several sampled tissues were undetected, so their lack of signal alone is a poor test of assay sensitivity (HPA tissue IHC: not detected in listed negative tissues). |
| Intracellular location and processing | MTTP has a signal peptide at residues 1–18 and a mature chain at 19–894, without a transmembrane segment (UniProt P55157). Interpret staining against its ER and Golgi locations; the supplied record does not locate the catalog antibody's epitope (UniProt P55157: topology and processing). |
| Antibody validation and tissue reliability | HPA marks the available tissue IHC antibody HPA054862 uncertain and describes low consistency with RNA plus presumed off-target binding (HPA antibodies: IHC uncertain; HPA tissue IHC: uncertain). A matching distribution raises confidence in interpretation but does not independently establish target specificity. |
| ICC-IF comparison | Q: What can IF add? A: An ER-like pattern can support the localisation interpretation (HPA ICC-IF: ER supported). Cytosolic staining has uncertain support, and this IHC section does not establish an IF protocol or transfer IHC validation to IF (HPA ICC-IF: cytosol uncertain; HPA antibodies: application-specific status). |
| Antigen retrieval and assay settings | Use the catalog antibody's IHC-P directions and tissue controls to assess retrieval and dilution (general IHC practice). The supplied HPA and UniProt records give no MTTP-specific fixation or retrieval response, so a change in signal cannot be attributed to a documented MTTP sensitivity. |
| Situation | Likely cause | Next action |
|---|---|---|
| Intestinal reference tissue is blank. | The high-staining cell population may be absent from the section, or an assay step may have failed (HPA tissue IHC: high in intestinal glandular cells; general IHC practice). | Confirm glandular cells on the counterstain; check the run's positive control, then review the catalog IHC-P retrieval, dilution, and detection settings (general IHC practice). |
| Liver is faint while intestinal glands stain clearly. | This difference is compatible with reported staining levels (HPA tissue IHC: hepatocytes medium; intestinal glandular cells high). | Compare the same cell types and scoring threshold across sections; retain the intestinal reference when judging assay performance (general IHC practice; HPA tissue IHC: high intestine). |
| Nuclei or cell borders dominate the stain. | The compartment disagrees with the reported ER and Golgi localisation and absence of a transmembrane segment (UniProt P55157). | Review counterstain and tissue morphology, then compare omission and other assay controls for nonspecific deposition (general IHC practice). Do not count the discordant compartment as pattern-confirming MTTP. |
| Reported negative cell populations stain strongly. | Cross-reactivity or endogenous detection activity is plausible, especially given the uncertain tissue IHC assessment (HPA tissue IHC: presumed off-target binding; general IHC practice). | Check a no-primary control for detection background and compare the suspect population with the listed HPA-negative examples (general IHC practice; HPA tissue IHC: listed negatives). |
| Chromogen appears widespread or obscures the expected cells. | Background may reflect blocking, detection, or antibody concentration settings (general IHC practice); the broad distribution does not match HPA's reported tissue profile (HPA tissue IHC). | Inspect no-primary and positive controls; adjust the relevant blocking, wash, or dilution step according to the catalog IHC-P workflow (general IHC practice). |
| IHC is ambiguous, and an IF comparison is being considered. | HPA supports ER localisation by ICC-IF but calls the cytosolic component uncertain (HPA ICC-IF: ER supported; cytosol uncertain). | Use the ER observation only as a localisation cross-check, and assess IF with its own application validation (HPA ICC-IF; HPA antibodies: application-specific status). |
Comprehensive Human Protein Atlas IHC scoring per tissue (reliability: Uncertain — Low consistency between antibody staining and RNA expression data. Presumed off target binding observed and disregarded.). Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Duodenum | Glandular cells | High | Protein (IHC) | HPA → |
| Small intestine | Glandular cells | High | Protein (IHC) | HPA → |
| Liver | Hepatocytes | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | Adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | Glandular cells | Not detected | Protein (IHC) | HPA → |
| Bone marrow | Hematopoietic cells | Not detected | Protein (IHC) | HPA → |
| Breast | Adipocytes | Not detected | Protein (IHC) | HPA → |
Use compartment, cell type and matched controls to evaluate MTTP staining in paraffin sections; the available tissue IHC reliability assessment is uncertain (HPA tissue IHC).
The IHC-validated anti-MTTP antibody has paraffin-section images from human liver cancer and rat liver, plus IF data from HEPG2 cells (A01715-1 image captions).
A01715-1 will render with its IHC figure from a paraffin-embedded human liver cancer section; a second catalog caption documents rat liver IHC (A01715-1 IHC captions). The same SKU lists IF and ICC applications and has an IF image from HEPG2 cells (catalog applications; A01715-1 IF caption).
Which to pick: Choose A01715-1 for chromogenic paraffin-section IHC in human or rat tissue: its own captions document EDTA pH 8 retrieval and DAB detection; the fixative is unreported (A01715-1 IHC captions). For IF/ICC, the same SKU lists both applications and shows IF in HEPG2 cells at 5 μg/mL (catalog applications; A01715-1 IF caption). For cross-species planning, human and rat have IHC captions; Monkey is listed as reactive without an IHC figure, and clonality is unreported (A01715-1 IHC captions; catalog reactivity; catalog clone).